Boehringer Ingelheim BI 1305-0014
Key Trial Information
- Trial Location: NSW
- Trial Status: Closed to recruitment
- Trial Type: Interventional
- Trial Disease Type: Interstitial Lung Disease (ILD)
- Trial Age Group: Over 18 years
- Trial Participant Type: Patient